Abstract:Colorectal cancer (CRC) is a prevalent form of gastrointestinal malignancy with challenges in chemotherapy resistance and side effects. Effective and low toxic drugs for CRC treatment are urgently needed. Ferroptosis is a novel mode of cell death, which has garnered attention for its therapeutic potential against cancer. Baicalein (5, 6, 7-trihydroxyflavone) is the primary flavone extracted from the dried roots of Scutellaria baicalensis that exhibits anticancer effects against several malignancies including CRC. In this study, we investigated whether baicalein induced ferroptosis in CRC cells. We showed that baicalein (1–64 μM) dose-dependently inhibited the viability of human CRC lines HCT116 and DLD1. Co-treatment with the ferroptosis inhibitor liproxstatin-1 (1 μM) significantly mitigated baicalein-induced CRC cell death, whereas autophagy inhibitor chloroquine (25 μM), necroptosis inhibitor necrostatin-1 (10 μM), or pan-caspase inhibitor Z-VAD-FMK (10 μM) did not rescue baicalein-induced CRC cell death. RNA-seq analysis confirmed that the inhibitory effect of baicalein on CRC cells is associated with ferroptosis induction. We revealed that baicalein (7.5–30 μM) dose-dependently decreased the expression levels of GPX4, key regulator of ferroptosis, in HCT116 and DLD1 cells by blocking janus kinase 2 (JAK2)/STAT3 signaling pathway via direct interaction with JAK2, ultimately leading to ferroptosis in CRC cells. In a CRC xenograft mouse model, administration of baicalein (10, 20 mg/kg, i.g., every two days for two weeks) dose-dependently inhibited the tumor growth with significant ferroptosis induced by inhibiting the JAK2/STAT3/GPX4 axis in tumor tissue. This study demonstrates that ferroptosis contributes to baicalein-induced anti-CRC activity through blockade of the JAK2/STAT3/GPX4 signaling pathway, which provides evidence for the therapeutic application of baicalein against CRC.

Baicalein mediates anticancer effect on cholangiocarcinoma through co-targeting the AKT/NF-κB and STAT3 signaling pathway

Baicalein Inhibits The Invasion, Migration And Epithelial-Mesenchymal Transition Of Bgc-823 Cells Through Nf-Kappa B/Snail Signaling Pathway

Preferential Inhibition of Hepatocellular Carcinoma by the Flavonoid Baicalein Through Blocking MEK-ERK Signaling

Baicalein: A Review of Its Anti-Cancer Effects and Mechanisms in Hepatocellular Carcinoma.

The most recent progress of baicalein in its anti-neoplastic effects and mechanisms

Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells.

Baicalein Attenuates Hepatocellular Carcinoma Cell Survival and Induces Apoptosis Through the miR‑3178/HDAC10 pathway

Baicalein Inhibits The Invasion And Metastatic Capabilities Of Hepatocellular Carcinoma Cells Via Down-Regulation Of The Erk Pathway

Mir‐3,178 Contributes to the Therapeutic Action of Baicalein Against Hepatocellular Carcinoma Cells Via Modulating HDAC10

Baicalein Inhibits Pancreatic Cancer Cell Proliferation and Invasion Via Suppression of NEDD9 Expression and Its Downstream Akt and ERK Signaling Pathways.

Baicalein Inhibits Progression of Gallbladder Cancer Cells by Downregulating Zfx

Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice

Network Pharmacology and Bioinformatics Approach Reveals the Therapeutic Mechanism of Action of Baicalein in Hepatocellular Carcinoma

Baicalein and Baicalin Inhibit Colon Cancer Using Two Distinct Fashions of Apoptosis and Senescence

Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2/STAT3/GPX4 axis

MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling

Baicalein: A review on its anti-cancer effects and mechanisms in lung carcinoma

Baicalein Inhibits Gastric Cancer Cell Proliferation and Migration Through a FAK Interaction Via AKT/mTOR Signaling.

Baicalein Facilitates Gastric Cancer Cell Apoptosis by Triggering Endoplasmic Reticulum Stress Via Repression of the PI3K/AKT Pathway

Baicalein Inhibits DMBA/TPA-Induced Skin Tumorigenesis in Mice by Modulating Proliferation, Apoptosis, and Inflammation

MiR-3663-3p Participates in the Anti-Hepatocellular Carcinoma Proliferation Activity of Baicalein by Targeting SH3GL1 and Negatively Regulating EGFR/ERK/NF-?B Signaling